Organism 67555 - Aspergillus candidus (HYPHOMYCETES)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon7847
FamilyHYPHOMYCETES
GenusASPERGILLUS
SpeciesCANDIDUS
Species authority
SubspeciesSTRAIN 592
Subspecies authority
Comment
CitationALVI,KA: PU,H: LUCHE,M: RICE,A: APP,H: MC MAHON,G: DARE,H: MARGOLIS,B:. (1999). ASTERRIQUINONES PRODUCED BY ASPERGILLUS CANDIDUS INHIBIT BINDING OF THE GRB-2 ADAPTER TO PHOSPHORYLATED EGF RECEPTOR TYROSINE KINASE.. 52(3)
Geographical areaNORTH AMERICA
CountryUSA-NV

Experiments

Filters
Worktypes (9)
7
7
7
7
7
7
7
6
1
No match
Pharmacology (2)
7
7
No match
Compounds (7)
2
2
2
2
2
2
2
No match
14 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
237025
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5220,NEO:
237026
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5220,NEO:
237027
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5228
237028
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5228
237029
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5500
237030
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5500
237031
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5503
237032
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5503
237033
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE,ISO:
237034
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE,ISO:
237035
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5501
237036
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5501
237037
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5504
237038
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN TYROSINE PHOSPHORYLATION INHIBITION
Aspergillus candidus (HYPHOMYCETES)
ASTERRIQUINONE SU-5504
Show SPARQL Queries (1)